StemCor Systems, Inc. is a clinical stage medical device company developing proprietary, disposable, minimally invasive technologies to serve the rapidly emerging field of point-of-care Regenerative Medicine. The technologies include the harvest, processing and delivery of adult, bone marrow-derived stem cells. Marrow-derived stem cells are currently used in bone marrow transplantation (BMT) and for applications in an expanding array of regenerative therapies, including orthopedics, diabetes & cardiovascular diseases [treatment of myocardial infarction (MI), congestive heart failure (CHF), peripheral artery disease (PAD)].

The Company has secured FDA clearance and the CE Mark for its first product, the MarrowMiner®, which is currently undergoing clinical evaluation. The technology was exclusively licensed from Stanford University. Extensive patent applications have been filed and complementary technologies have been licensed or acquired. StemCor’s development activities are now focused on downstream applications such as stem cell processing and site-specific delivery – integrating seamlessly with the MarrowMiner in application-specific kits for multiple therapeutic areas

Click on the section titles below to navigate our website. If you have comments or questions, please send us an email.